Emergent BioSolutions Inc.·4

Feb 10, 7:11 PM ET

Perl Jessica 4

4 · Emergent BioSolutions Inc. · Filed Feb 10, 2026

Research Summary

AI-generated summary of this filing

Updated

Emergent BioSolutions SVP Jessica Perl Sells 918 Shares for Taxes

What Happened

  • Jessica Perl, Senior Vice President, General Counsel and Corporate Secretary of Emergent BioSolutions (EBS), had 918 shares of company stock withheld to satisfy tax withholding obligations related to the vesting/settlement of restricted stock units (RSUs). The withholding was recorded as a disposition of 918 shares at $11.03 per share, total value $10,126.
  • This was a tax-withholding transaction (routine disposition), not an open-market sale intended as a directional bet on the stock.

Key Details

  • Transaction date: 2026-02-09; filing date: 2026-02-10 (timely filing).
  • Action/code: F (shares withheld to pay taxes on RSU vesting).
  • Shares withheld/disposed: 918 at $11.03 each; total value reported $10,126.
  • Footnote: F1 — represents shares withheld to pay taxes associated with vesting and settlement of restricted stock units.
  • Shares owned after the transaction: not specified in this filing.

Context

  • Withholding shares to cover taxes is a common administrative step when RSUs vest (a cashless/net-share settlement) and does not necessarily indicate insider intent to sell shares on the open market.
  • For retail investors, purchases by insiders are often more informative about confidence than routine withholdings or disposals for tax purposes.

Insider Transaction Report

Form 4
Period: 2026-02-09
Perl Jessica
SVP, General Counsel, Corp Sec
Transactions
  • Tax Payment

    Common Stock

    [F1]
    2026-02-09$11.03/sh918$10,12667,469 total
Footnotes (1)
  • [F1]Represents shares of common stock withheld to pay taxes associated with vesting and settlement of restricted stock units
Signature
/s/ Richard S. Lindahl, Attorney-in-fact|2026-02-10

Documents

1 file
  • 4
    wk-form4_1770768677.xmlPrimary

    FORM 4